Navigation Links
Angiotech announces exclusive distribution agreement with B. Braun for Angiotech's proprietary Quill(TM) SRS product line
Date:5/3/2010

ive barbed monofilament sutures fit very well with our global monofilament sutures campaign, and we are convinced that it will be a major breakthrough for our organization in these markets," said Mr. Miguel Pablo, Vice President, Marketing, Sales & Regulatory Affairs for the Closure Technologies Unit in the B. Braun Group. "With this agreement, we proudly strengthen our strategic partnership with Angiotech, a leading company in innovative treatment solutions," added Mr. Pablo.

B. Braun is one of the world's leading health care suppliers with over (euro)4 billion in revenue in 2009 and over 39,000 employees worldwide. Its Aesculap division focuses on products and services for core processes in surgery. Aesculap's product portfolio includes, among other items, surgical instruments for open or minimally invasive approaches, implants (including for orthopedics, neurosurgery and spinal surgery), surgical sutures, sterile containers, storage, motor and navigation systems, and products for cardiology.

Forward Looking Statements

Statements contained in this press release that are not based on historical fact, including without limitation statements containing the words "believes," "may," "plans," "will," "estimates," "continues," "anticipates," "intends," "expects" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and constitute "forward-looking information" within the meaning of applicable Canadian securities laws. All such statements are made pursuant to the "safe harbor" provisions of applicable securities legislation. Forward- looking statements may involve, but are not limited to, comments with respect to our objectives and priorities for the remainder of 2010 and beyond, our strategies or future actions, our targets, expectations for our financial c
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
2. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
3. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
4. Angiotech to participate in UBS Global Life Sciences Conference
5. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
6. Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line
7. Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook
8. Angiotech to participate in Bank of America 2007 Credit Conference
9. Angiotech to participate in RBC 2007 Healthcare Conference
10. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
11. Athersys and Angiotech announce authorization of Phase I intramyocardial stem cell U.S. clinical trial in acute myocardial infarction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... ... $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and ... aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Currently deployed within several ... developed to solve many of the complex logistical and data management challenges associated ... clinical sites and/or remote data coordination centers. , CentrePoint drastically reduces personnel ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... Polytechnic Institute (WPI), offers new insights into how virulent fungi adapt through genetic ... spread, and how that battle leaves them temporarily weakened. These insights may provide ...
(Date:7/6/2015)... , July 6, 2015  Emdeon ... into a definitive agreement to acquire Altegra ... intervention platforms that combine data aggregation and ... capabilities to achieve actionable insights and improved ... combine Altegra Health,s risk adjustment and quality ...
Breaking Biology Technology:Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 2Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 4Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 5ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 2ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4
... June 17 Berlin Heart Inc. today,announced it has ... FDA,to support the ongoing Investigational Device Exemption (IDE) study ... Almond of,the Children,s Hospital of Boston, and Bob Kroslowitz, ... serve as Co-Principal,Investigators for the grant project "Safety and ...
... , ... More Seed Options in the Marketplace. , ... Des Moines, Iowa, and Atlanta, Ind. (Vocus) June 17, 2009 –- Pioneer ... have entered into research and distribution agreements to bring additional corn and soybean products to ...
... N.C., June 17 Campbell Alliance, the leading management ... today announced that it has appointed industry veterans Jon ... Both gentlemen will work directly with John Campbell, ... areas to advise the firm,s emerging and midsize client ...
Cached Biology Technology:Berlin Heart Inc. Receives FDA Orphan Product Development Grant 2Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements 2Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements 3Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 2Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 3Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 4
(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... June 23, 2015   Valencell, a ... results of a recent study that illustrates its ... wrist during activity. In a study conducted at ... along with the Apple Watch against a chest ... rate during activity. The study demonstrated that Valencell,s ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces that its ... segment on "Money on the Mark", scheduled to air on ... June 20 th . The broadcast ... from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... strongly predisposes carriers to develop cancer at an early ... researchers today at the American Association for Cancer Research ... person should have two normal copies of the powerful ... as Li-Fraumeni syndrome (LFS), one defective copy of p53 ...
... Curcumin, the yellowish component of turmeric that gives curry ... anti-cancer properties. Researchers from Tohoku University in Sendai, ... two molecular analogues of curcumin that demonstrate even greater ... the first test of these molecules in a mouse ...
... international team of scientists today announced the results of ... lung cancer, the worlds leading cause of cancer deaths. ... the journal Nature, the research provides a comprehensive view ... revealing more than 50 genomic regions that are frequently ...
Cached Biology News:Rare cancer-causing syndrome found, for the first time, in Singapore 2Curry-derived molecules might be too spicy for colorectal cancers 2Genome study charts genetic landscape of lung cancer 2Genome study charts genetic landscape of lung cancer 3
Mouse monoclonal [DAPK-55] to DAP Kinase 1 ( Abpromise for all tested applications). entrezGeneID: 1612 SwissProtID: P53355...
Mouse monoclonal [1.T.4] to WAVE 1 ( Abpromise for all tested applications). Antigen: His6 fusion protein corresponding to full-length rat WAVE1. Entrez Gene ID: 8936...
KOR-1 (C-20)...
KV beta.1 (Q-13)...
Biology Products: